Skip to main content

Advertisement

Log in

Is the Presence of Depression Independent from Signs of Disease Activity in Patients with Neurocysticercosis?

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Neurocysticercosis (NCC) is a common central nervous system (CNS) infection caused by Taenia solium metacestodes. Depression is present in 53–85% of the NCC patients. The present study was aimed to evaluate the correlation of signs of NCC activity (evolution phase of NCC cysts and CSF characteristics) with depression. The study group consisted of 65 patients subdivided into two groups: NCC with epilepsy (48) and NCC without epilepsy [17]. Depression was assessed and quantified by the Hamilton Rating Scale for Depression (HRSD-21) and compared with CSF inflammatory characteristics (increase of WBCs and total protein) and presence of calcifications or cysts. There was no difference between the scores of depression in the group with CNS calcifications or cysts. CSF signs of active disease, specifically increase of CSF TP, were significantly more frequent in patients with mild depression and in non-depressant patients. The depression scores were inversely proportional to the CSF TP levels in the groups with depression. Although immunological factors could be associated with the development of depression, the data above lead us to make assumptions about the association of other factors such as genetic predisposition, or social and cultural factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CSF:

Cerebrospinal fluid

HCV:

Hepatitis C virus

HRSD:

Hamilton Rating Scale for Depression

IL:

Interleukin

LP:

Lumbar puncture

NCC:

Neurocysticercosis

TP:

Total protein

WBC:

White blood cell

References

  1. Del Brutto, O. H., & Sotelo, J. (1988). Neurocysticercosis: An update. Reviews of infectious diseases, 10, 1075–1087.

    Article  PubMed  CAS  Google Scholar 

  2. De Giorgio, C. M., Sorvillo, F., Wallin, M. T., Escueta, S. P., & Kurtzke, J. F. (2005). Neurocysticercosis in the United States: Review o fan important emerging infection. Neurology, 64, 1486.

    Google Scholar 

  3. Takayanagui, O. M., & Jardim, E. (1983). Therapy for neurocysticercosis: Comparison between albendazole and praziquantel. Archives of Neurology, 49, 290–294.

    Google Scholar 

  4. Garcia, H. H., & Del Bruto, O. H. (2005). Neurocysticercosis:Updated concepts about an old disease. Lancet Neurology, 4, 653–661.

    Article  PubMed  Google Scholar 

  5. Andrade-Filho, A. S., Souza, A. P. Q. U., & Souza, Y. M. A. (1997). Neurocisticercose. Revisão. Parte I. RBNP, 1, 125–130.

    Google Scholar 

  6. Ong, S., Talan, D. A., Moran, G. J., Mower, W., Newdow, M., & Tsang, V. C. (2002). Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerging Infectious Diseases, 8, 608–613.

    Article  PubMed  Google Scholar 

  7. Ko, D. (2003) Seizures in neurocysticercosis at LAC USC Medical Center. Epilepsia, 44, 15.

  8. Richards, F. O., Schantz, P. M., Ruiz-Tiben, E., & Sorvillo, F. J. (1985). Cysticercosis in Los Angeles County. JAMA, 254, 3444–3448.

    Article  PubMed  Google Scholar 

  9. Ramirez-Bermudez, J., Higuera, J., Sosa, A. L., Lopez-Meza, E., Lopez-Gomez, M., & Corona, T. (2005). Is dementia recersible im patients with neurocysticercosis? Journal of Neurology, Neurosurgery and Psychiatry, 76, 1164–1166.

    Article  CAS  Google Scholar 

  10. Forlenza, O. V., Filho, A. H., Nobrega, J. P., dos Ramos Machado, L., de Barros, N. G., de Camargo, C. H., et al. (1997). Psychiatric manifestations in neurocysticercosis: A study of 38 patients from a neurology clinic in Brazil. Journal of Neurology, Neurosurgery and Psychiatry, 62, 612–616.

    Article  CAS  Google Scholar 

  11. Almeida, S. M., & Gurjão, S. A. (2010). Frequency of depression among patients with neurocysticercosis. Arquivos de neuro-psiquiatria., 68, 76–80.

    Article  PubMed  Google Scholar 

  12. Del Brutto O. H., Rajshekhar V., White A. C. Jr, Tsang V. C., Nash T. E., Takayanagui O. M., et al.(2001) Proposed diagnostic criteria for neurocysticercosis. Neurology, 24(57),177–83.

  13. Sotelo, J., Guerrero, V., & Rubio, F. (1985). Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Archives of Internal Medicine, 145, 442–445.

    Article  PubMed  CAS  Google Scholar 

  14. Hamilton, M. (1960). Rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56.

    Article  CAS  Google Scholar 

  15. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8–19.

    PubMed  CAS  Google Scholar 

  16. Bastos, F. O. (1953). Aspectos psiquiatricos da neurocisticercose. Revista Paulista de Medicina, 43, 162–164.

    Google Scholar 

  17. Pupo P. P., Cardoso W., Reis J. B., Silva C. P. Sobre a cisticercose encefálica: estudo clínico, anátomo patológico, radiológico e do LCR. Arquivos Assist Psicopatology 1945/1946, 10/113–123.

  18. Tretiakoff, C., & Pacheco e Silva, A. C. (1924). Contribuição para o estudo da cysticercose cerebral e em particular das lesões cerebraes tóxicas a distancia nesta afecção. Memórias do Hospício Juqueri, 1, 37–66.

    Google Scholar 

  19. Atkinson, J. H., Heaton, R. K., Patterson, T. L., Wolfson, T., Deutsch, R., Brown, S. J., et al. (2008). Two-year prospective study of major depressive disorder in HIV-infected men. Journal of Affective Disorders, 108, 225–234.

    Article  PubMed  Google Scholar 

  20. Loftis, J. M., Huckans, M., Ruimy, S., Hinrichs, D. J., & Hauser, P. (2008). Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neuroscience Letters, 430, 264–268.

    Article  PubMed  CAS  Google Scholar 

  21. Restrepo, B. I., Alvarez, J. I., Castaño, J. A., Arias, L. F., Restrepo, M., Trujillo, J., et al. (2001). Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infection and Immunity, 69, 4554–4560.

    Article  PubMed  CAS  Google Scholar 

  22. Chavarría, A., Fleury, A., García, E., Márquez, C., Fragoso, G., & Sciutto, E. (2005). Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clinical Immunology, 116, 271–278.

    Article  PubMed  Google Scholar 

  23. Aguilar-Rebolledo, F., Cedillo-Rivera, R., Llaguno-Violante, P., Torres-López, J., Muñoz-Hernandez, O., & Enciso-Moreno, J. A. (2001). Interleukin levels in cerebrospinal fluid from children with neurocysticercosis. American Journal of Tropical Medicine and Hygiene, 64, 35–40.

    PubMed  CAS  Google Scholar 

  24. Uddin, J., Gonzalez, A. E., Gilman, R. H., Garcia, H. H., Verastegui, M., Moore, L. J., et al. (2006). Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway. Microbes and infection, 8, 1732–1740.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergio Monteiro de Almeida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Almeida, S.M., Gurjão, S.A. Is the Presence of Depression Independent from Signs of Disease Activity in Patients with Neurocysticercosis?. J Community Health 36, 693–697 (2011). https://doi.org/10.1007/s10900-011-9362-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-011-9362-x

Keywords

Navigation